N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide

C20H16F3N7O2 — CID 121265781

IUPACN-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide
SMILESNc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5nnc(C(F)(F)F)o5)cc4)c12)CCC3
InChIInChI=1S/C20H16F3N7O2/c21-20(22,23)19-29-28-15(32-19)8-14(31)27-10-4-6-11(7-5-10)30-13-3-1-2-12(13)16-17(30)18(24)26-9-25-16/h4-7,9H,1-3,8H2,(H,27,31)(H2,24,25,26)
InChIKeyUUOWINDICUBEPA-UHFFFAOYSA-N
MW443.39 g/mol
LogP3.07
Rot. Bonds4

About N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide

N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide (PubChem CID 121265781) has the molecular formula C20H16F3N7O2 and a molecular weight of 443.39 g/mol. Its IUPAC name is N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide.

Molecular Properties

Compound NameN-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide
PubChem CID121265781
Molecular FormulaC20H16F3N7O2
Molecular Weight443.39 g/mol
Exact Mass443.13
IUPAC NameN-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide
SMILESNc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5nnc(C(F)(F)F)o5)cc4)c12)CCC3
InChIInChI=1S/C20H16F3N7O2/c21-20(22,23)19-29-28-15(32-19)8-14(31)27-10-4-6-11(7-5-10)30-13-3-1-2-12(13)16-17(30)18(24)26-9-25-16/h4-7,9H,1-3,8H2,(H,27,31)(H2,24,25,26)
InChIKeyUUOWINDICUBEPA-UHFFFAOYSA-N
XLogP3.07
TPSA124.75 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500443.39
LogP ≤ 53.07
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide?
The IUPAC name of N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide (CID 121265781) is N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide.
What is the SMILES notation for N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide?
The canonical SMILES for N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide is Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5nnc(C(F)(F)F)o5)cc4)c12)CCC3.
What is the InChIKey of N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide?
The InChIKey is UUOWINDICUBEPA-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H16F3N7O2/c21-20(22,23)19-29-28-15(32-19)8-14(31)27-10-4-6-11(7-5-10)30-13-3-1-2-12(13)16-17(30)18(24)26-9-25-16/h4-7,9H,1-3,8H2,(H,27,31)(H2,24,25,26).
What are the key properties of N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide?
N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide has a molecular weight of 443.39 g/mol, XLogP of 3.07, 4 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(9-amino-7,10,12-triazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-7-yl)phenyl]-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide is sourced from PubChem (CID 121265781), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).